Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Aktionärsstruktur

Inhaber in %
Freefloat 99.83
The Vanguard Group, Inc. 8.54
Vanguard Group, Inc. (Subfiler) 8.11
State Street Corp. 4.26
Capital Research & Management Co. (World Investors) 3.17
Vanguard Total Stock Market ETF 3.14
Vanguard 500 Index Fund 2.47
T Rowe Price Associates, Inc. (13F Subfiler) 2.42
BlackRock Fund Advisors 2.27
BlackRock Institutional Trust Co. NA 2.17
Capital Research & Management Co. (Global Investors) 2.07
Geode Capital Management LLC 1.89
Fidelity Management & Research Co. LLC 1.61
Government Pension Fund - Global (The) 1.44
Norges Bank (13F) 1.42

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 75’000 80’000 130’000 130’000 122’000
Umsatz pro Mitarbeiter in Mio. EUR 0.34 0.40 0.30 0.35 0.35

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 11’893 21’957 20’113 25’229 24’589
Summe Anlagevermögen 48’165 57’052 77’132 80’051 83’159
Summe Aktiva 58’381 69’052 95’123 97’154 98’726

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 18’490 22’545 36’339 36’073 36’424
Summe Fremdkapital 28’706 34’545 54’146 53’006 51’884
Summe Eigenkapital 29’675 34’507 40’977 44’148 46’842
Summe Passiva 58’381 69’052 95’123 97’154 98’726

Adresse

168 Third Avenue, 02451 Waltham
Telefon +1 (781) 622-1000
Fax +1 (781) 622-1207
URL http://www.thermofisher.com

Management

Aditya Joshi
Chief Strategy Officer & Vice President
Alan B. Sachs
Chief Medical Officer
Anthony Hugh Smith
Treasurer, Vice President-Tax & Treasury
C. Martin Harris
Independent Director
Chetan Khanna
Director-Human Resources
Cory Stevenson
President-Bioproduction Division
Daniel P. Shine
Senior VP, President-Analytical Instruments
Daniella Cramp
Senior VP & President-BioProduction Group
David Johnston
Senior Vice President-Clinical Research
Debora L. Spar
Independent Director
Dion J. Weisler
Independent Director
Frederick M. Lowery
Senior VP & President-Customer Channels
Garret Hampton
President-Clinical Sequencing & Oncology
Gianluca Pettiti
Executive Vice President
James C. Mullen
Director
Jennifer M. Johnson
Director
John Brian Sabo
VP & General Counsel-Customer Channels Group
Joseph Holmes
Chief Accounting Officer & Vice President
Julia L. Chen
Secretary & Vice President
Karen E. Nelson
Chief Scientific Officer
Kathryn Miles
Vice President-Strategic Accounts
Kimberlee S. Caple
Vice President & GM-Genetic Science Business
Lars Rebien Sørensen
Independent Director
Lisa P. Britt
Chief Human Resources Officer & Senior VP
Marc N. Casper
Chairman, President & Chief Executive Officer
Michael A. Boxer
Senior Vice President & General Counsel
Michael J. Dubose
President-Fisher Healthcare Division
Michel Lagarde
Chief Operating Officer & Executive Vice President
Mike Shafer
Senior VP & President-Pharma Services Group
Nelson J. Chai
Independent Director
Paul G. Parker
Senior VP-Strategy & Corporate Development
R. Alexandra Keith
Independent Director
Rafael Tejada
Vice President-Investor Relations
Ruby R. Chandy
Independent Director
Ryan Snyder
Chief Information Officer & Senior Vice President
Scott M. Sperling
Lead Independent Director
Stephen Williamson
Chief Financial Officer & Senior Vice President
Tyler E. Jacks
Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen